{"id":401420,"date":"2026-01-09T06:33:17","date_gmt":"2026-01-09T06:33:17","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/401420\/"},"modified":"2026-01-09T06:33:17","modified_gmt":"2026-01-09T06:33:17","slug":"can-this-healthcare-stock-keep-going-after-a-nearly-70-surge","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/401420\/","title":{"rendered":"Can This Healthcare Stock Keep Going After a Nearly 70% Surge?"},"content":{"rendered":"<p> Amneal Pharmaceuticals <a class=\"mention\" href=\"https:\/\/www.barchart.com\/quotes\/AMRX\" target=\"_self\" data-symbol=\"AMRX\" rel=\"nofollow noopener\">(AMRX)<\/a> is trading at new 5-year highs with strong technical momentum.AMRX has gained 69% over the past year.Shares maintain a 100% \u201cBuy\u201d technical opinion on Barchart.Analyst sentiment is positive, with multiple \u201cStrong Buy\u201d ratings and price targets as high as $15.\u00a0Today\u2019s Featured Stock<\/p>\n<p>Valued at $3.98 billion, Amneal Pharmaceuticals <a class=\"mention\" href=\"https:\/\/www.barchart.com\/quotes\/AMRX\" target=\"_self\" data-symbol=\"AMRX\" rel=\"nofollow noopener\">(AMRX)<\/a> is an integrated specialty pharmaceutical company. It focuses on developing, manufacturing, and distributing generic, brand, and biosimilar products. The company operates primarily in North America, Asia, and Europe.<\/p>\n<p>What I\u2019m Watching<\/p>\n<p>I found today\u2019s Chart of the Day by using Barchart\u2019s powerful screening functions to sort for stocks with the highest technical buy signals; superior current momentum in both strength and direction; and a\u00a0<a target=\"_blank\" href=\"https:\/\/www.barchart.com\/education\/technical-indicators\/trend-seeker\" rel=\"nofollow noopener\">Trend Seeker \u201cbuy\u201d signal<\/a>. I then used Barchart\u2019s\u00a0<a target=\"_blank\" href=\"https:\/\/www.barchart.com\/education\/site-features\/flipcharts\" rel=\"nofollow noopener\">Flipcharts feature<\/a>\u00a0to review the charts for consistent price appreciation. AMRX checks those boxes. Since the Trend Seeker signaled a new \u201cBuy\u201d on Oct. 22, the stock has gained 27.56%.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"aspect-ratio:1614\/649;\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/01\/366229-17677348410339391_origin.png\" width=\"1614\" height=\"649\"\/><a target=\"_blank\" href=\"https:\/\/www.barchart.com\/stocks\/quotes\/AMRX\/interactive-chart\" rel=\"nofollow noopener\">www.barchart.com<\/a>Barchart Technical Indicators for Amneal Pharmaceuticals<\/p>\n<p>Editor\u2019s Note:\u00a0The technical indicators below are updated live during the session every 20 minutes and can therefore change each day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the\u00a0Barchart.com website when you read this report. These technical indicators form the Barchart Opinion on a particular stock.<\/p>\n<p>Amneal Pharma scored a new 5-year high of $13.37 on Jan. 7.<\/p>\n<p>AMRX has a Weighted Alpha of +83.10.Amneal Pharma has a 100% \u201cBuy\u201d opinion from Barchart.The stock gained 68.74% over the past year.AMRX has its Trend Seeker \u201cBuy\u201d signal intact.The stock recently traded at $13.23 with a 50-day moving average of $12.Amneal Pharma made 12 new highs and gained 9.03% in the last month.Relative Strength Index (RSI) is at 68.22.There\u2019s a technical support level around $12.76.Don\u2019t Forget the Fundamentals$3.98 billion market capitalization.18.81x trailing price-earnings ratio.Revenue is expected to grow 7.83% this year and another 6.67% next year.Earnings are estimated to increase 37.67% this year and an additional 16.04% next year.Analyst and Investor Sentiment on Amneal Pharmaceuticals<a target=\"_blank\" href=\"https:\/\/www.barchart.com\/stocks\/quotes\/AMRX\/analyst-ratings\" rel=\"nofollow noopener\">Wall Street analysts tracked by Barchart<\/a>\u00a0have given 5 \u201cStrong Buy\u201d and 1 \u201cHold\u201d opinion on the stock with price targets between $13 and $15.Value Line ranks the stock \u201cAverage.\u201dCFRA\u2019s MarketScope Advisor rates the stock as \u201cHold.\u201dMorningstar thinks with the stock\u2019s recent runup, it\u2019s still fairly valued.9,200 investors are monitoring the stock on Seeking Alpha, which rates the stock a \u201cStrong Buy.\u201dShort Interest is just 1.70% of the float.The Bottom Line on Amneal Pharmaceutical<\/p>\n<p>Wall Street views this stock favorably and predicts decent increases in both revenue and earnings.\u00a0<\/p>\n<p>Additional disclosure:\u00a0The Barchart Chart of the Day highlights stocks that are experiencing exceptional current price appreciation. They are not intended to be buy recommendations as these stocks are extremely volatile and speculative. Should you decide to add one of these stocks to your investment portfolio it is highly suggested you follow a predetermined diversification and moving stop loss discipline that is consistent with your personal investment risk tolerance.<\/p>\n<p>\n    On the date of publication,<\/p>\n<p>    <a target=\"_self\" href=\"https:\/\/www.barchart.com\/news\/authors\/46\/jim-van-meerten\" rel=\"nofollow noopener\">Jim Van Meerten<\/a><\/p>\n<p>            did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes.<\/p>\n<p>    For more information please view the Barchart Disclosure Policy<\/p>\n<p>    <a target=\"_self\" href=\"https:\/\/www.barchart.com\/terms#disclosure\" rel=\"nofollow noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Amneal Pharmaceuticals (AMRX) is trading at new 5-year highs with strong technical momentum.AMRX has gained 69% over the&hellip;\n","protected":false},"author":2,"featured_media":401421,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500,40949],"class_list":{"0":"post-401420","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-healthcare","12":"tag-n-a"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/401420","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=401420"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/401420\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/401421"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=401420"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=401420"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=401420"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}